Akso Health Group (AHG) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Akso Health Group

NASDAQ: AHG · Real-Time Price · USD
1.62
0.02 (1.25%)
At close: Oct 03, 2025, 2:53 PM
1.58
-2.47%
After-hours: Oct 03, 2025, 04:16 PM EDT

Akso Health Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Revenue
14.78M 11.62M 8.45M 5.43M 2.41M 2.32M 2.22M 7.7M 13.18M 15.24M 17.61M 11.81M 6M 1.72M -1.11M -553.65K n/a 2.43M 3.11M 6.97M
Cost of Revenue
15.06M 11.62M 8.18M 5.24M 2.29M 2.16M 2.04M 6.97M 11.91M 11.5M 10.91M 6.39M 1.02M 6.61M 13.05M 13.67M 20.11M 14.44M 8.1M 8.87M
Gross Profit
-281.53K -2.74K 276.05K 199.09K 122.13K 152.04K 181.94K 725.47K 1.27M 6,311.1B 6,311.1B 6,311.1B 6,311.1B -15.06M -24.34M -23.84M -29.73M 107.23B 107.23B 107.24B
Operating Income
-166.3M -86.58M -6.86M -7.75M -8.64M -12.5M -16.36M -15.31M -14.27M 13.15M 16.54M 7.73M 3.91M -27M -29.2M -43.87M -47.68M 75.86B 75.86B 75.87B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 102.07K 402.07K 702.07K 702.07K 1.1M 1.38M 1.66M 1.66M 1.78M 1.2M
Pretax Income
-166.27M -86.42M -6.57M -7.83M -9.09M -13.43M -17.76M -15.42M -13.07M 12.63M 16.08M 15.25M 9.97M -21.1M -24M -24M -28.27M 76.54B 76.52B 76.51B
Net Income
-134.98M -70.78M -6.58M -7.82M -9.06M -13.48M -17.89M -15.54M -13.2M 8.93M 12.37M 28.45M 23.18M -11.65M -14.7M -15.29M -19.59M 65.53B 65.51B 65.48B
Selling & General & Admin
3.64M 5.39M 7.14M 7.95M 8.76M 12.65M 16.54M 16.04M 15.54M 14.95M 9.3M 12.69M 16.07M 10.92M 21.94M 19.86M 17.78M 21.05B 21.04B 21.05B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 14.7K 127.35K 240K 460.7K 666.7K 554.05K 441.41K 279.67K 117.94K 117.94K
Other Expenses
162.38M 81.19M -722.82K -722.82K -722.82K -722.82K n/a n/a n/a n/a n/a n/a n/a 4.35M 4.35M 4.35M 4.35M n/a n/a n/a
Operating Expenses
166.02M 86.58M 6.42M 7.59M 8.76M 12.99M 17.95M 16.67M 15.4M -18.99M -24.8M -20.79M -16.78M 15.88M 27.21M 25.31M 23.42M 21.05B 21.06B 21.07B
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 643.2K
Selling & Marketing Expenses
n/a 84.21K 168.42K 168.42K 168.42K 131.01K 93.59K 143.72K 193.85K 676.38K 671.89K 699.92K 727.96K 1.02M 1.24M 1.44M 1.64M 1.07M 1.05M 10.04M
Cost & Expenses
181.08M 98.2M 15.32M 13.55M 11.78M 15.88M 19.98M 23.65M 27.31M -1.89M -8.29M -9.65M -11.01M 21.65M 39.42M 43.96M 48.51M 31.39B 31.39B 31.4B
Income Tax Expense
30.88M 15.46M 39.03K 32.01K 24.99K 27.83K 30.67K 24.11K 17.55K 3.64M 3.69M 3.68M 3.69M 4.17M 4.32M 4.32M 4.35M 11.03B 11.03B 11.03B
Shares Outstanding (Basic)
332.55M 332.55M 77.72M 77.72M 20.81M 20.79M 7.62M 7.62M 7.42M 7.42M 8.25M 8.25M 6.62M 6.06M 5.5M 5.5M 5.43M 5.42M 5.43M 5.43M
Shares Outstanding (Diluted)
337.18M 337.18M 77.67M 77.67M 23.83M 23.83M 7.62M 7.62M 7.62M 7.62M 7.62M 7.62M 6.62M 6.13M 5.63M 5.63M 5.43M 5.42M 5.43M 5.43M
EPS (Basic)
-0.42 -0.36 -0.3 -0.48 -0.69 -1.53 -2.37 -2.07 -1.77 1.44 1.77 4.71 3.81 -2.13 -2.76 -2.82 -3.63 13.11K 13.11K 13.1K
EPS (Diluted)
-0.42 -0.33 -0.26 -0.45 -0.66 -1.5 -2.31 -2.01 -1.71 1.47 1.77 4.68 3.78 -2.16 -2.79 -2.79 -3.63 12.38K 12.37K 12.37K
EBITDA
-1.77M -1.15M -523.78K -261.89K n/a -7.02M -14.04M -14.14M -14.24M 1.83M 5.22M 1.39M -2.44M 7.74M 5.56M 1.9M -1.76M -29.54M -32.31M -34.26M
EBIT
-3.92M -5.39M -6.86M -7.75M -8.64M -12.5M -16.36M -15.31M -14.27M 1.8M 5.19M 1.37M -2.46M 7.73M 5.52M 1.72M -2.09M -29.89M -32.64M -33.7M
Depreciation & Amortization
2.15M 4.24M 6.34M 7.49M 8.64M 5.48M 2.33M 1.18M 25.35K -7.74M -7.74M -16.65M -16.65M -22.07M -22.04M -30.58M -30.44M -17.23M -17.26M 281.26K